Ergothioneine Technical Guide: OCTN1 Transport, Antioxidant Mechanism & Formulation | Onerchem
◆ Antioxidants
Ergothioneine is structurally unlike any other antioxidant used in cosmetics. It contains a thiohistidine core that is unusually stable against oxidation, and the human body has a dedicated transporter — OCTN1 — that actively concentrates it into cells experiencing oxidative stress. This guide covers the chemistry, the cellular uptake mechanism, formulation requirements, and what to verify when sourcing cosmetic-grade EGT.
What is Ergothioneine — structure and origin
Ergothioneine (L-Ergothioneine, EGT, CAS 497-30-3) is a naturally occurring amino acid derivative first identified in ergot fungi in 1909. It is found in significant concentrations in mushrooms, certain bacteria, and in smaller amounts in foods including black beans, oat bran, and red meat — where it originates from fungi and bacteria consumed by animals rather than being synthesised by the animals themselves.
Structurally, ergothioneine is a betaine derivative of 2-thiolhistidine, characterised by a thione group (C=S) on the imidazole ring rather than a free thiol (SH). This structural feature is critical to its stability:
- Thione vs thiol stability — Most sulphur-containing antioxidants (glutathione, cysteine, N-acetylcysteine) contain free thiol (SH) groups that oxidise readily in air to form disulphides. Ergothioneine's thione tautomer is significantly more stable — it does not readily oxidise under standard atmospheric conditions, does not form disulphides, and does not generate the reactive oxidation products that can cause instability or irritation from thiol-based antioxidants.
- Zwitterionic form at physiological pH — Ergothioneine exists predominantly as a zwitterion (both positively and negatively charged groups) at physiological pH. This charge distribution contributes to its high water solubility and its recognition by the OCTN1 transporter.
| Parameter | Value |
|---|---|
| INCI Name | Ergothioneine |
| CAS Number | 497-30-3 |
| Chemical name | (S)-α-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-1H-imidazole-4-ethanaminium inner salt |
| Molecular formula | C₉H₁₅N₃O₂S |
| Molecular weight | 229.30 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely water soluble — approximately 100 g/L at 25°C |
| pH stability | Stable across pH 4.0–8.0 in aqueous solution |
| Heat stability | Stable to 100°C in aqueous solution — can be added to heated water phase |
| Commercial production | Fermentation-derived (fungal or bacterial fermentation) — not synthetic |
| Regulatory status | EU CosIng listed · IECIC · US cosmetic permitted CosIng ↗ |
OCTN1 transport — the mechanism that sets EGT apart
The most scientifically distinctive aspect of ergothioneine is that the human body has a dedicated transporter protein for it. OCTN1 (Organic Cation/Carnitine Transporter Novel 1, encoded by the SLC22A4 gene) was identified as a high-affinity ergothioneine transporter in research published in the mid-2000s.
OCTN1 is a membrane transport protein that actively imports ergothioneine from extracellular fluid into cells. Key characteristics relevant to cosmetic application:
- Active, energy-dependent transport — OCTN1 transports ergothioneine against a concentration gradient, using cellular energy. This means cells can accumulate ergothioneine at concentrations higher than in the surrounding environment — a property that distinguishes EGT from passive-diffusion antioxidants.
- Expression in skin cell types — OCTN1 is expressed in keratinocytes, fibroblasts, and other skin-relevant cell types, supporting the biological plausibility of topical ergothioneine uptake into skin cells. Research indicates OCTN1 expression may increase under oxidative stress conditions — directing EGT accumulation to where it is most needed.
- Topical vs dietary — important nuance — The tissue accumulation of ergothioneine that has been most extensively studied is from dietary intake (ergothioneine is concentrated in erythrocytes, liver, kidney, and lens). The degree to which topically applied cosmetic ergothioneine achieves comparable cellular accumulation via OCTN1 in skin is not fully established and remains an active area of research. Published in-vitro data supports cellular uptake from topical application; the clinical magnitude in intact skin in-vivo requires further research. Claims about topical EGT should be grounded in available data rather than extrapolating from dietary intake studies.
The existence of a dedicated transporter is not simply a marketing talking point — it reflects a genuine evolutionary relationship. Humans cannot synthesise ergothioneine and must obtain it from dietary sources; the OCTN1 transporter suggests the body evolved to actively conserve and concentrate this compound wherever oxidative stress occurs.
Antioxidant mechanism — what EGT quenches and how
Ergothioneine's antioxidant activity involves several mechanisms operating at different levels:
Reactive oxygen species scavenging
Ergothioneine is effective against several ROS relevant to UV-exposed skin, based on published in-vitro chemistry data:
- Singlet oxygen (¹O₂) quenching — Ergothioneine quenches singlet oxygen — the primary ROS generated by UV-sensitised reactions in skin. Singlet oxygen quenching by EGT involves both chemical quenching (reaction with the thione group) and physical quenching (energy transfer without chemical transformation). Published in-vitro data supports EGT as an effective singlet oxygen quencher, though direct rate constant comparisons to other quenchers vary by experimental conditions.
- Hydroxyl radical scavenging — Ergothioneine has demonstrated hydroxyl radical scavenging activity in published in-vitro assays. Hydroxyl radicals are highly reactive and damaging — they cause lipid peroxidation, DNA strand breaks, and protein oxidation.
- Peroxynitrite interaction — Research has documented ergothioneine's reactivity with peroxynitrite, a reactive nitrogen species generated under inflammatory conditions. This may contribute to EGT's anti-inflammatory activity profile beyond its direct antioxidant function.
Metal chelation
The thione group of ergothioneine can coordinate with certain transition metal ions (particularly Cu²⁺ and Fe²⁺/Fe³⁺) that catalyse Fenton and Haber-Weiss reactions generating hydroxyl radicals. By chelating these catalytic metal ions, ergothioneine can prevent metal-catalysed radical generation. This is distinct from its direct radical scavenging — it addresses the source of radical generation rather than the radicals themselves.
Regeneration Capacity
Unlike many antioxidants that are consumed stoichiometrically when they neutralise a radical, ergothioneine shows some capacity for regeneration — the oxidised form (ergothioneine sulphoxide or sulphone) can be partially reduced back to the active thione form enzymatically within cells. This regeneration capacity means that cellular ergothioneine can provide antioxidant protection beyond a simple one-to-one neutralisation of reactive species. The extent of regeneration in skin cells under cosmetic use conditions is not fully characterised in published literature.
Ergothioneine vs other cosmetic antioxidants
Ergothioneine
CAS 497-30-3 · Thiohistidine Betaine
Stability
Excellent — thione form stable in air, no disulphide formation, pH 4.0–8.0
Cellular uptake
Active — OCTN1 transporter-mediated accumulation in skin cells
Primary ROS targets
Singlet oxygen, hydroxyl radical, peroxynitrite; metal chelation
Formulation
Water phase, pH 4.0–8.0, heat stable to 100°C — very easy to formulate
Cost relative
Premium — fermentation production; higher cost than commodity antioxidants
3-O-Ethyl Ascorbic Acid
Stable Vitamin C Derivative
Stability
Good — much more stable than L-Ascorbic Acid, but some oxidation sensitivity above pH 6.5
Cellular uptake
Passive diffusion; enzymatic conversion to Ascorbic Acid in skin
Primary ROS targets
Superoxide, hydroxyl radical; reduces oxidised melanin intermediates — brightening activity
Formulation
Water phase, pH 4.0–7.5; amphiphilic — distributes in both phases
Cost relative
Moderate — established production, competitive pricing
Tocopherol (Vitamin E)
Fat-Soluble Antioxidant
Stability
Moderate — effective in oil phase; can become pro-oxidant at high concentrations or with metal contamination
Cellular uptake
Passive diffusion via lipid membrane integration
Primary ROS targets
Lipid peroxyl radicals — primary lipid membrane antioxidant; chain-breaking activity in oxidative cascades
Formulation
Oil phase only; incompatible with aqueous phase without solubilisation
Cost relative
Low to moderate — commodity ingredient, widely available
Combination Strategy
Ergothioneine, Vitamin C derivatives, and Tocopherol address different ROS in different cellular compartments (cytoplasm, membrane, extracellular). A complete antioxidant formula uses all three in complementary roles: EGT in the water phase for cytoplasmic and singlet oxygen protection, 3-O-EAA for both phases with brightening activity, and Tocopherol in the oil phase for lipid membrane protection. This is the same multi-mechanism logic applied in the PIH brightening serum — different tools for different targets.
Target applications
Premium Anti-Aging Serums
Primary application — EGT addresses UV-induced and metabolic ROS that drive collagen degradation and accelerated skin ageing. Position alongside peptides (Matrixyl, GHK-Cu) for combined structural repair + antioxidant protection.
0.5–1.0%
Post-UV Exposure Recovery
Singlet oxygen and lipid peroxidation are primary post-UV damage pathways. EGT's singlet oxygen quenching and OCTN1-mediated uptake make it well-suited for after-sun and UV-recovery positioning.
0.5–1.0%
Brightening Formulas
Anti-pigmentation activity via melanin synthesis pathway interference has been explored in published research, in addition to EGT's primary antioxidant role. Combine with Alpha-Arbutin, TXA, and Niacinamide for comprehensive brightening coverage.
0.3–0.5%
Sensitive & Compromised Skin
Anti-inflammatory properties alongside antioxidant activity make EGT appropriate for sensitive, reactive, and post-procedure skin. Compatible with Ectoine, Ceramide NP, and Panthenol in barrier-focused formulas.
0.5%
Concentrations based on published cosmetic use data. Efficacy claims require formula-specific in-vitro or in-vivo validation before commercial use.
Formulation protocol
Ergothioneine is one of the most formulation-friendly premium actives available — its stability, water solubility, and wide pH tolerance impose very few constraints on formula design.
- Water phase addition — Ergothioneine dissolves readily in water at ambient temperature. Add directly to the water phase — no pre-dissolution solvent, no heating required. Can be added at any point in water phase preparation.
- Heat stable to 100°C — EGT can be included in the heated water phase of emulsion production without activity loss. No cool-down addition requirement — simplifies manufacturing protocols.
- Stable pH 4.0–8.0 — Compatible with essentially all cosmetic pH ranges. No acidic pH requirement. Formula pH can be optimised for other actives without compromising EGT stability.
- Compatible with common actives — Ergothioneine is compatible with peptides (Matrixyl, AH-8, GHK-Cu), Niacinamide, Sodium Hyaluronate, Alpha-Arbutin, Tranexamic Acid, Vitamin C derivatives, and standard preservative systems. No known incompatibilities at typical cosmetic use concentrations.
- No special packaging required — EGT's stability means it does not require airless, opaque, or nitrogen-flushed packaging for preservation. Standard pump or airless packaging is appropriate, though airless is generally preferred for premium antioxidant serums to minimise oxygen exposure over product life.
- Avoid high concentrations of reducing metals in the formula — Like most antioxidants, EGT performs best when trace metal contamination in the water phase is minimised. Use demineralised water (conductivity <5 µS/cm) and include Disodium EDTA (0.05%) as a chelating agent, particularly in formulas containing multiple antioxidants.
Product Page · Antioxidants
Ergothioneine (CAS 497-30-3) — Fermentation-derived, HPLC ≥98%, batch COA, EU CosIng compliant
View Product
→
Sourcing notes — fermentation grade and COA requirements
Commercial ergothioneine is produced exclusively by fermentation — primarily using fungi (Claviceps purpurea relatives) or engineered bacterial systems. There is no practical synthetic route to ergothioneine at commercial scale. This means sourcing quality is primarily determined by fermentation process control and downstream purification.
- HPLC purity ≥98% with chromatogram — The primary quality specification. The chromatogram should show a single dominant peak at the ergothioneine retention time. Key impurity to watch for: ergothioneine sulphoxide (oxidised form), which appears as a separate peak. Any significant sulphoxide peak indicates oxidative degradation during production or storage.
- Optical purity — L-form confirmation — The naturally occurring and biologically active form is L-Ergothioneine. Confirm the stereoisomer in the COA. Some synthetic routes produce racemic mixtures; fermentation-derived EGT is the L-form by nature of biosynthesis.
- Heavy metals — quantitative values — Fermentation-derived materials carry inherent heavy metal risk from growth media. Request quantitative Pb, As, Cd, Hg values — not "Pass." Confirm these are below relevant cosmetic use limits.
- Residual solvents — Downstream purification of fermentation-derived EGT typically uses organic solvents. Request residual solvent testing confirming levels below ICH Q3C Class 2 limits or equivalent.
- Storage: sealed, cool, dry — Ergothioneine powder is hygroscopic and should be stored in a sealed container below 25°C away from moisture. While the thione form is stable against air oxidation, prolonged exposure to high humidity can cause caking and reduce solubility rate. Confirm storage conditions were maintained before delivery.
For a complete guide to evaluating cosmetic ingredient COAs, see How to Read a Cosmetic Ingredient COA.
Frequently asked questions
Two structural features distinguish EGT: its thione group on the imidazole ring is significantly more stable than standard thiol antioxidants (no disulphide formation, air-stable), and it has a dedicated cellular transporter — OCTN1 — that actively concentrates it into cells under oxidative stress. No other cosmetic antioxidant has this active cellular uptake mechanism. These properties make EGT's stability and potential bioavailability profile distinct from Vitamin C derivatives, Tocopherol, or Glutathione.
OCTN1 (SLC22A4) is a membrane transporter protein that actively imports ergothioneine into cells against a concentration gradient. It is expressed in keratinocytes, fibroblasts, and other skin cell types, and is upregulated under oxidative stress conditions — directing EGT accumulation where it is most needed. Published in-vitro data supports cellular uptake of topically applied EGT via OCTN1 in skin cells. The degree to which topical application replicates the tissue accumulation seen from dietary ergothioneine in-vivo is not fully established and remains an active research area.
Based on published cosmetic use data, typically 0.1–1.0% in finished formulas. Premium anti-aging and antioxidant positioning uses 0.5–1.0%. Below 0.1% provides limited contribution. EGT is water-soluble and stable across pH 4.0–8.0 — add directly to the water phase, heat stable to 100°C, no special processing required. Efficacy claims for specific products require formula-specific validation.
Ergothioneine has an extensive human safety record as a dietary compound — present in mushrooms and other foods consumed throughout human history. Listed in EU CosIng and permitted under Regulation (EC) No 1223/2009. Also in IECIC and permitted in US cosmetics. At cosmetic use concentrations (0.1–1.0%), it has a well-established safety profile with no known sensitisation, phototoxicity, or irritation concerns. Its unique stability (does not oxidise to form reactive species) also distinguishes it from less stable thiol antioxidants. Source: EU CosIng ↗.